| Absorption |
| Blood-Brain Barrier | BBB- | 0.9961 |
| Human Intestinal Absorption | HIA- | 0.9270 |
| Caco-2 Permeability | Caco2- | 0.8956 |
| P-glycoprotein Substrate | Substrate | 0.5603 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9626 |
| Non-inhibitor | 0.9971 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9689 |
| Distribution |
| Subcellular localization | Lysosome | 0.5707 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8297 |
| CYP450 2D6 Substrate | Non-substrate | 0.8447 |
| CYP450 3A4 Substrate | Non-substrate | 0.5825 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9253 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9402 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9401 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9399 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8309 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9884 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9998 |
| Non-inhibitor | 0.9031 |
| AMES Toxicity | Non AMES toxic | 0.9132 |
| Carcinogens | Non-carcinogens | 0.5363 |
| Fish Toxicity | High FHMT | 0.9722 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.7152 |
| Honey Bee Toxicity | Low HBT | 0.7369 |
| Biodegradation | Not ready biodegradable | 0.9844 |
| Acute Oral Toxicity | IV | 0.6698 |
| Carcinogenicity (Three-class) | Non-required | 0.6941 |